The Walgreens Center for Health & Wellbeing Research
Welcome to the Walgreens Center for Health & Wellbeing Research.
Walgreens strives to impact the Triple Aim by improving the experience of care, improving the health of populations and reducing total health care costs. Our dedicated team works to demonstrate the impact and effectiveness of various pharmacy-led programs and services and how they can benefit patients, providers and payers.
Here you will find summaries, links and original documents related to our research in peer-reviewed publications and presentations at scientific conferences.
We look forward to your feedback and our efforts to improve health and wellness in America! If you have questions or suggestions, please contact us at firstname.lastname@example.org.
National Surveillance of COVID-19
Click here to view Walgreens COVID-19 Index
Interactive maps and graphs tracking COVID-19, including Omicron, and other emerging variants are updated daily.
Aegis Sciences Corporation and Walgreens COVID-19 diagnostic testing and whole genome sequencing contains ~15% of all COVID-19 results in the United States. The combination of diagnostic testing, genome sequencing, and patient information produces valuable epidemiologic insights.
Article describes an early indicator of the Omicron variant.
94% of patients on direct acting antivirals had sustained virologic response (SVR) 12 weeks after therapy: 1
1. Zhu, J., Hazen, R., Joyce, C. Delpino, A., Kirhkam, H., Strickland, C., Markes-Wilson, S., Kim, T., Kang, M., Rubin, R. and Stein, L. (2017). Local specialty pharmacy and specialty clinic collaboration assists access to hepatitis C direct-acting antivirals. Journal of the American Pharmacists Association. Article in Press. https://dx.doi.org/10.1016/j.japh.2017.10.011
The data reported is from Walgreens Specialty Pharmacy patients with fills from 11/2013 to 6/2015.